Literature DB >> 25192602

The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.

Julie Kaiser-Guignard1, Giorgia Canellini2, Niels Lion3, Mélanie Abonnenc4, Jean-Claude Osselaer5, Jean-Daniel Tissot6.   

Abstract

Since 1990, several techniques have been developed to photochemically inactivate pathogens in platelet concentrates, potentially leading to safer transfusion therapy. The three most common methods are amotosalen/UVA (INTERCEPT Blood System), riboflavin/UVA-UVB (MIRASOL PRT), and UVC (Theraflex-UV). We review the biology of pathogen inactivation methods, present their efficacy in reducing pathogens, discuss their impact on the functional aspects of treated platelets, and review clinical studies showing the clinical efficiency of the pathogen inactivation methods and their possible toxicity.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Amotosalen; Hemovigilance; Pathogen inactivation; Pathogen reduction; Platelet concentrates; Platelets; Riboflavin; Transfusion

Mesh：

Substances：

Year:  2014        PMID： 25192602     DOI： 10.1016/j.blre.2014.07.005

Source DB:  PubMed          Journal:  Blood Rev        ISSN： 0268-960X            Impact factor:   8.250


  24 in total

Review 1.  Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.

Authors:  Victor J Drew; Lassina Barro; Jerard Seghatchian; Thierry Burnouf
Journal:  Blood Transfus       Date:  2017-04-13       Impact factor: 3.443

2.  In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.

Authors:  M Shukla; U D S Sekhon; V Betapudi; W Li; D A Hickman; C L Pawlowski; M R Dyer; M D Neal; K R McCrae; A Sen Gupta
Journal:  J Thromb Haemost       Date:  2017-02       Impact factor: 5.824

3.  Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.

Authors:  Dragoslav Domanović; Ines Ushiro-Lumb; Veerle Compernolle; Sergio Brusin; Markus Funk; Pierre Gallian; Jørgen Georgsen; Mart Janssen; Teresa Jimenez-Marco; Folke Knutson; Giancarlo M Liumbruno; Polonca Mali; Giuseppe Marano; Yuyun Maryuningsih; Christoph Niederhauser; Constantina Politis; Simonetta Pupella; Guy Rautmann; Karmin Saadat; Imad Sandid; Ana P Sousa; Stefania Vaglio; Claudio Velati; Nicole Verdun; Miguel Vesga; Paolo Rebulla
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

4.  Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light.

Authors:  Carme Ballester-Servera; Teresa Jimenez-Marco; Daniel Morell-Garcia; Miguel Quetglas-Oliver; Antonia M Bautista-Gili; Enrique Girona-Llobera
Journal:  Blood Transfus       Date:  2020-05-15       Impact factor: 3.443

5.  Zika Virus (ZIKV).

Authors: 
Journal:  Transfus Med Hemother       Date:  2016-10-14       Impact factor: 3.747

6.  The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Authors:  Andreas Engert; Carlo Balduini; Anneke Brand; Bertrand Coiffier; Catherine Cordonnier; Hartmut Döhner; Thom Duyvené de Wit; Sabine Eichinger; Willem Fibbe; Tony Green; Fleur de Haas; Achille Iolascon; Thierry Jaffredo; Francesco Rodeghiero; Gilles Salles; Jan Jacob Schuringa
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 7.  Improving platelet transfusion safety: biomedical and technical considerations.

Authors:  Olivier Garraud; Fabrice Cognasse; Jean-Daniel Tissot; Patricia Chavarin; Syria Laperche; Pascal Morel; Jean-Jacques Lefrère; Bruno Pozzetto; Miguel Lozano; Neil Blumberg; Jean-Claude Osselaer
Journal:  Blood Transfus       Date:  2015-11-16       Impact factor: 3.443

8.  Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.

Authors:  Johanna Reckhaus; Markus Jutzi; Stefano Fontana; Vera Ulrike Bacher; Marco Vogt; Michael Daslakis; Behrouz Mansouri Taleghani
Journal:  Transfus Med Hemother       Date:  2018-05-24       Impact factor: 3.747

Review 9.  Proteomics: A Tool to Study Platelet Function.

Authors:  Olga Shevchuk; Antonija Jurak Begonja; Stepan Gambaryan; Matthias Totzeck; Tienush Rassaf; Tobias B Huber; Andreas Greinacher; Thomas Renne; Albert Sickmann
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

10.  Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.

Authors:  Frédéric Garban; Audrey Guyard; Helene Labussière; Claude-Eric Bulabois; Tony Marchand; Christiane Mounier; Denis Caillot; Jacques-Olivier Bay; Valérie Coiteux; Aline Schmidt-Tanguy; Catherine Le Niger; Christine Robin; Patrick Ladaique; Simona Lapusan; Eric Deconinck; Carole Rolland; Alison M Foote; Anne François; Chantal Jacquot; René Tardivel; Pierre Tiberghien; Jean-Luc Bosson
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.